IPO Price History
Closed
Concord Biotech Limited logo

Concord Biotech Limited IPO

Mainboard IPOListedCONCORDBIONSE
Current Market Price (CMP)
₹1,229.30(+65.90%)
Current Price (CMP)
₹1,229.30(+65.90%)

Live Market Quote

Listing Price & Gain
₹900.05(+21.46%)

Day 1 Exchange Open

IPO Issue Price
₹741

Band: ₹705 - ₹741

Total Subscription
24.87x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
04 Aug 2023
IPO Bidding Closes
08 Aug 2023
Allotment & Refunds
Completed
Exchange Listing Day
18 Aug 2023

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 24.87x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)67.67x
Non-Institutional Investors (NII / HNI)16.99x
Retail Individual Investors (RII)3.78x
Employees Reservation24.48x
Total Subscription24.87x
Updated as on 08-Aug-2023 19:00:00

Listing Day & Return Performance

Listing Day Gain+21.46%
₹741 (Issue) → ₹900.05 (List)
Per share profit: +₹159.05
Holding Return (Till Date)+65.90%
₹741 (Issue) → ₹1,229.30 (CMP)
Net gain per share: +₹488.30
Post-Listing Performance (Listing Day → Today):+36.58%

About Concord Biotech Limited IPO

Concord Biotech Limited is an Indian public offering categorized under the Mainboard segment. The public issue opened for bidding on 04 Aug 2023 and concluded on 08 Aug 2023, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹705 - ₹741.

During the bidding window, Concord Biotech Limited witnessed heavy demand with an overall subscription of 24.87 times. Institutional investors (QIB) subscribed 67.67x, non-institutional high-net-worth investors (NII) subscribed 16.99x, and retail individual investors (RII) bid 3.78x their reserved quota, alongside employee participation of 24.48x.

The equity shares of Concord Biotech Limited officially debuted on the stock exchanges on 18 Aug 2023 at an opening listing price of ₹900.05, delivering a listing day return of +21.46% (premium) over the final issue price. As per the latest market data, the stock trades at ₹1,229.30, representing an overall gain of +65.90% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Concord Biotech Limited IPO?
The issue price of Concord Biotech Limited IPO was fixed at ₹741 per equity share. The indicative bidding price band was ₹705 - ₹741.
What were the open, close, and listing dates for Concord Biotech Limited IPO?
Concord Biotech Limited IPO opened on 04 Aug 2023, closed on 08 Aug 2023, listed on 18 Aug 2023.
How much was Concord Biotech Limited IPO subscribed?
The IPO received an overall subscription of 24.87 times. Category-wise, QIBs subscribed 67.67x, NIIs subscribed 16.99x, and Retail investors subscribed 3.78x.
What was the listing price and listing gain of Concord Biotech Limited IPO?
Concord Biotech Limited IPO listed on the stock exchange at ₹900.05, delivering a listing gain of 21.46% compared to the IPO issue price of ₹741.
Is Concord Biotech Limited IPO a Mainboard or SME IPO?
Concord Biotech Limited IPO is a Mainboard IPO listed on the main exchange of NSE.
What is the current return of Concord Biotech Limited IPO since its IPO?
At the latest market quote of ₹1,229.30, Concord Biotech Limited IPO has generated an all-time return of +65.90% since its initial public offering.

Related Mainboard IPOs (2023)

INNOVACAP
Innova Captab Limited
₹448+0.92%
AZAD
Azad Engineering Limited
₹524+37.40%
RBZJEWEL
RBZ Jewellers Limited
₹1000.00%
MUFTI
Credo Brands Marketing Limited
₹280+0.84%